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CVD risk stratification for population health
Assessment of a person’s total or absolute risk of a cardiovascular disease (CVD) event based
on multiple risk factors is superior to assessment of single risk factors when identifying who is
at greatest risk of a CVD event [1]. In this issue of PLOS Medicine, a study by Rifat Atun and
colleagues outlines the use of CVD risk prediction equations for population health rather than
for clinical purposes [2]. This has inherent appeal because risk stratification of a population
could be used to drive policy and health service planning, inform funding decisions around
subsidising treatments, and identify particular subgroups for more intensive intervention
strategies.
Atun and colleagues used 2012 and 2014 household health survey data to assess sociodemo-
graphic and geographic variation in CVD risk profiles across most states and union territories
in India. Cross-sectional estimates of 10-year CVD risk were derived using the Framingham
risk equation (FRE) for people aged 30 to 74 years, calibrated for India using 2015 Global Bur-
den of Disease data. Sensitivity analyses were conducted using three other risk prediction
equations that have also been calibrated with Indian data. The main finding is the identifica-
tion of regional ‘hotspots’ of relatively higher CVD risk scores regardless of which risk predic-
tion equation was used. Furthermore, positive associations were found with increasing
household and district wealth in both rural and urban areas. Although urban areas overall had
a stronger positive association with higher CVD risk scores, the district wealth gradient was
more pronounced in rural compared with urban areas, and the household wealth gradient was
greater for females compared with males.
The multivariable, absolute risk paradigm is now commonplace in many management
guidelines around the world; however, there remain challenges with its implementation. First,
the validity of cohort-derived risk prediction equations applied to other populations is fre-
quently questioned [3]. Second, when risk factor prevalence rates and CVD incidence rates are
rapidly changing due to demographic and socioeconomic changes in the community, the need
to recalibrate such equations becomes important [4]. Third, when assessing the effectiveness of
risk-based interventions, most studies are based on simulation studies [5] rather than empiri-
cal trial data [6]. Finally, although risk prediction equations were designed to guide decisions
on management and intervention, the evidence that use of risk scores improves clinical out-
comes remains unclear [7].
The limitations of Atun and colleagues’ study are related to these broader challenges of
implementing the risk-based paradigm. First, none of the equations used have been validated
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with longitudinal data from Indian cohorts. Consequently, the absolute values of the risk pro-
files presented in this paper cannot be relied on. The wide variation in risk estimates between
the FRE scores and WHO risk charts and Globorisk scores is concerning, and there is cur-
rently no way of knowing which is the most accurate. Second, the survey data that were relied
on are now over 5 years old, and, given rapid demographic transitions across India, the risk
estimates may not reflect the contemporary situation. This is a general limitation with risk pre-
diction equations. WHO risk charts are currently being recalibrated with country-specific
data, but this is the first time this has been done since the original risk charts were published in
2007. Third, 27% of the survey sample did not have sufficient information to assess risk, and
males with missing data appear to be a little better educated, wealthier, and more likely to
reside in an urban setting. Finally, the surveys did not ascertain a history of a prior CVD event.
Assuming that the entire population studied are event free will greatly underestimate risk
profiles.
Implications for cardiovascular risk reduction in India
The implications of this work are complex and inevitably will mean different things for differ-
ent sectors. Epidemiologists may be unimpressed by the variation in risk profiles generated by
the four equations and conclude that, in the absence of a gold standard equation, the principal
findings are of questionable value. Clinicians and health service administrators may be
focussed on the challenges of implementing absolute risk assessments in clinical practice.
India, like many countries, uses hybrid guidelines that include a combination of risk scores
and single risk factor thresholds for determining treatment decisions. For example, those with
an elevated blood pressure of greater than or equal to 160/100 mmHg are considered to be
clinically high-risk regardless of their risk scores [8]. This approach seeks to strike a middle
ground for those who may have reservations about a pure risk-based approach and may make
it easier for nonphysician workers when conducting household screening assessments [9].
These implementation challenges highlight the need for reliable equations with variables that
can be easily and cheaply measured by staff with low levels of training. An important implica-
tion from Atun and colleagues’ study is that cohort derived-equations in India that incorporate
measures of wealth and geographic location, such as those derived in the United Kingdom and
Scotland, may be needed [10].
For policy makers, however, it would be unwise to wait for perfect data to create the perfect
policies. Access gaps to essential care are large, and action is needed now. There are broadly
two main policy levers to lower CVD risk—population- and individual-level approaches. Pop-
ulation-level approaches attempt to shift the distribution of risk of the whole community
through policies, laws, and regulations (e.g., improved food supply, healthy environments,
tobacco control). The risk profile heat maps generated in Atun and colleagues’ study could
guide where the most intensive efforts are needed. Individual-level approaches consist of CVD
risk assessment programs implemented in healthcare facilities with thresholds set for defining
intervention intensity. A universal screening program for all adults is unlikely to be the best
use of scarce resources, and targeted programs are likely to be more cost-effective [11]. A more
detailed appraisal of regional risk profiles, such as those generated in Atun and colleagues’
study, could therefore assist with economic modelling and investment decisions.
Furthermore, given the wide variation in risk profile, the resource implications for inter-
vention similarly will vary greatly by region. Health technology assessments could play a vital
role in driving these decisions. India’s new Medical Technology Assessment Board will engage
multisectoral representatives to provide recommendations on the value of particular health
interventions, programs, and technologies [12]. These assessments could better inform
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strategic purchasing arrangements and the design of benefit packages that are based on popu-
lation need rather than simply trying to meet service demand [13].
Although better risk profile data are critical for the design and funding of evidence-based pro-
grams, an equally important challenge is overcoming implementation barriers of these programs.
The National Programme For Prevention and Control of Cancer, Diabetes, Cardiovascular Dis-
ease and Stroke, established in 2008, has faced major resource challenges to build primary health-
care workforce capacity and address both supply and demand side barriers to implementation
[14]. The recently announced Ayushman Bharat National Health Protection Scheme plans to pro-
vide publicly funded health insurance to cover over 100 million poor families in India and
upgrade over 150,000 subcentres to health and wellness centres [15]. Although there are major
questions regarding the resourcing and management of such an ambitious program, it does pro-
vide the opportunity for revitalisation of the primary healthcare system, new workforce initiatives,
and improved access to affordable treatments. Data-informed, regionally specific CVD risk pro-
grams could play a central role in such programs and drive system improvements across India.
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